Pregnancy outcomes of patients with positive anticentromere antibodies receiving in vitro fertilization-embryo transfer

Yuqing Tian; Yi'er Zhou; Yuhang Fan; Sufeng Chen; Xiaoyan Guo; Yiqi YU; Xiangli WU; Weihai XU; Jing Shu

Return

Pregnancy outcomes of patients with positive anticentromere antibodies receiving in vitro fertilization-embryo transfer

VernacularTitle:抗着丝点抗体阳性患者体外受精结局分析
Author: Yuqing TIAN ^{1
,

2} ; Yi'er ZHOU ; Yuhang FAN ; Sufeng CHEN ; Xiaoyan GUO ; Yiqi YU ; Xiangli WU ; Weihai XU ; Jing SHU
Author Information

1. 锦州医科大学研究生院,辽宁锦州 121001
2. 浙江省人民医院生殖内分泌科,浙江杭州 310014
Keywords: Anticentromere antibodies; In vitro fertilization-embryo transfer; Multiple pronucleus fertilization; Oocyte maturity; Embryonic development; Pregnancy outcome
From: Journal of Zhejiang University. Medical sciences 2024;53(3):342-350
CountryChina
Language:Chinese
Abstract: Objective:To analyze the pregnancy outcomes in patients with positive anti-centromere antibodies(ACA)receiving in vitro fertilization(IVF)-embryo transfer(ET)and natural conception.Methods:A case-control study was used to retrospectively analyze the clinical data of 3955 patients who received IVF-ET therapy and had the results of antinuclear antibody(ANA)spectrum at Zhejiang Provincial People's Hospital from June 2016 to June 2023.Patients with positive ACA and negative ACA were matched at a ratio of 1∶3 using propensity score matching.Embryo outcomes of IVF were compared between the two groups,and the impact of different fertilization methods and the use of immunosuppressants on pregnancy outcomes were analyzed using self-matching.The natural conception and disease progress were followed up for ACA-positive patients after IVF failure.Results:The ACA-positive patients accounted for 0.86%of all IVF patients(34/3955)and 2.51%of total ANA-positive IVF patients.Regardless of whether patients received conventional IVF(c-IVF)or intracytoplasmic sperm injection(ICSI),the ACA-positive group exhibited significant differences in oocyte maturity and fertilization compared to the ACA-negative group(both P＜0.01).Moreover,the ACA-positive group had a decreased number of D3 suboptimal embryos and D3 optimal embryos(both P＜0.05).In 5 cases of ACA-positive patients who underwent ICSI cycles,the two pronucleus(2PN)rate did not increase compared to c-IVF cycles(P＞0.05),and there was a decrease in the number of D3 high-quality embryos and D3 suboptimal embryos(both P＜0.05).After 1-2 months of immuno-suppressant treatment,12 ACA-positive patients underwent c-IVF/ICSI again,and there were no changes in egg retrieval and fertilization before and after medication(both P＞0.05),but there was an improvement in the 2PN embryo cleavage rate(P＜0.05).The number of embryos transferred was similar between the ACA-positive and negative groups,but the ACA-positive group had significantly lower embryo implantation rate and clinical pregnancy rate compared to the ACA-negative group(both P＜0.05),with no significant differences in the miscarriage rate between the two groups(P＞0.05).Twenty-seven ACA-positive patients attempted natural conception or artificial insemination after IVF failure,resulting in a total of 7 cases of clinical pregnancy.Conclusions:Serum ACA positivity may disrupt oocyte maturation and normal fertilization processes,with no improvement observed with ICSI and immunosuppressant use.However,ACA-positive patients may still achieve natural pregnancy.